IBM (IBM) stock fell Thursday despite the tech giant reporting first-quarter earning and sales ahead of expectations. The tech giant gave a stronger-than-expected sales forecast for the current quarter, but a top executive cited an “uncertain” operating environment.
Big Blue announced late Wednesday that it earned an adjusted $1.60 per share on sales of $14.54 billion for the March-ended quarter. That came in ahead of analyst estimates that IBM would earn an adjusted $1.42 per share on sales of $14.39 billion. Sales increased 1% year-over-year while adjusted earnings decreased by 5% on a per-share basis.
↑ X NOW PLAYING Tariff Update: Trump Exempts These Tech Goods From 125% Hike As China Trade War Rages On IBM told investors it expects revenue of $16.4 billion to $16.75 billion for the current second quarter. That topped the $16.3 billion Q2 sales estimate that analysts had penciled in for IBM prior to the report.
“While no one is immune to uncertainty, we enter this environment from a position of relative strength and resiliency,” IBM Chairman and CEO Arvind Krishna said on a call with analysts Wednesday. “Our clients run the world’s most essential processes. Our diversity across businesses, geographies, industries and large enterprise clients position us well to navigate the current climate.”
IBM also reiterated its overall 2025 expectations that it first gave in January: constant-currency revenue growth of at least 5% and free cash flow of $13.5 billion for the full year.
On the stock market today, IBM stock was down more than 6% at 230 in premarket action. But IBM stock entered Thursday 33% higher compared to 12 months ago, outperforming a stock market that has slumped this year.
IBM Stock: Tariff, DOGE Impact
IBM does not typically provide quarterly sales forecasts. But Chief Financial Officer James Kavanaugh told analysts Thursday that the company wanted to provide greater transparency given the “very dynamic and uncertain macroeconomic environment.”
That uncertainty includes questions about the impact of President Donald Trump’s tariffs on the broader market, as well as concerns about cuts to federal IT contracts from the Elon Musk-led DOGE effort. The company addressed both concerns on the investor call Wednesday.
For tariffs, Krishna noted that goods imported to the U.S. represent “less than 5% of our overall spend, and under current U.S. tariff policy, the impact to IBM is minimal.”
Meanwhile, Kavanaugh told analysts that IBM is “not immune” to the government spending cuts driven by the DOGE initiative. But he said that U.S. government contracts represent less than 10% of IBM consulting revenue.
“It’s hard to predict where that goes over the rest of the year,” Krishna added. “So, I’m not going to try and make that prediction on DOGE and consulting, except to caution … if there is pressure in the economy, consulting tends to see headwinds before other parts of the business.”
IBM Growth Led By Software
Krishna said the company’s performance was led by strength for its software products.
“There continues to be strong demand for generative AI and our book of business stands at more than $6 billion inception-to-date, up more than $1 billion in the quarter,” Krishna said.
Software revenue rose 7% to of $6.34 billion. That was slightly ahead of the $6.33 billion consensus estimate from analysts.
Consulting revenue fell 2% year-over-year to $5.07 billion. That was slightly better than the $5.05 billion projected by analysts. And IBM’s infrastructure revenue decreased 6% to $2.89 billion, vs. estimates for $2.76 billion.
IBM Stock Is Up 12% This Year
Prior to earnings, IBM gained 1.9% in regular Wednesday trading. Shares have gained 12% so far this year despite the S&P 500 falling 8.6% year-to-date. Some analysts believe IBM can maintain the “safe haven” status for investors that allowed the company’s shares to outperform during previous economic slowdowns.
Despite seeing significant pressure that may impact discretionary projects for IBM products and services, we believe that IBM is well-positioned to navigate the macro storm and capitalize on the current demand shift for hybrid and AI applications with more enterprises looking to implement AI for productivity gains and drive long-term profitable growth,” Wedbush analyst Dan Ives wrote Thursday.
Ives reiterated an outperform call with a price target of 300.
Coming into the report, IBM stock had an IBD Composite Rating of 81 out a best-possible 99, according to IBD Stock Checkup. The score combines five separate proprietary ratings into one rating. The best growth stocks have a Composite Rating of 90 or better.
Further, IBM’s IBD Relative Strength Rating is 91 out of 99. The RS Rating means that IBM has outperformed 91% of all stocks in IBD’s database over the past year.
YOU MAY ALSO LIKE:
Cloud Infrastructure Growth Could Cool This Year Despite AI Excitement, Analyst Says
When To Sell Growth Stocks: This Could Be Your No. 1 Rule
Get Timely Buy & Sell Alerts With IBD Leaderboard
IBD Live: Learn And Analyze Growth Stocks With The Pros
How To Know It’s Time To Sell Your Favorite Stock
